NCT03652090 Primary Nasal Cell Culture as a Tool for Personalized Therapy in Cystic Fibrosis Status COMPLETED Phase N/A
NCT03647228 A Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of IONIS-ENaCRx in Healthy Volunteers and Patients With Cystic Fibrosis Status COMPLETED Phase PHASE1
NCT03645473 Evaluation of Device Settings for Airway Clearance Using The Monarch Airway Clearance System Status UNKNOWN Phase NA
NCT03637504 Feasibility of a Mobile Medication Plan Application in CF Patient Care Status COMPLETED Phase NA
NCT03633526 Evaluation of VX-659/TEZ/IVA in Cystic Fibrosis Subjects 6 Through 11 Years of Age Status TERMINATED Phase PHASE3
NCT03625466 A Study to Explore the Impact of Lumacaftor/Ivacaftor on Disease Progression in Subjects Aged 2 Through 5 Years With Cystic Fibrosis, Homozygous for F508del Status COMPLETED Phase PHASE2
NCT03624101 Novel Therapeutic Approaches for Treatment of CF Patients With W1282X Premature Termination Codon Mutations Status TERMINATED Phase PHASE4
NCT03622892 Non-invasive Prenatal Diagnosis of Monogenic Disorders by Linked-reads Technology Status UNKNOWN Phase N/A
NCT03607396 Study for Evaluating the Real Use of Inhaled Aztreonam Lysine in Patients With Cystic Fibrosis Status UNKNOWN Phase N/A
NCT03601637 Safety and Pharmacokinetic Study of Lumacaftor/Ivacaftor in Participants 1 to Less Than 2 Years of Age With Cystic Fibrosis, Homozygous for F508del Status COMPLETED Phase PHASE3
NCT03591094 Study Assessing PTI-428 Safety, Tolerability, Pharmacokinetics and Effect in Subjects With Cystic Fibrosis Status COMPLETED Phase PHASE2
NCT03589313 Pharmacokinetics of GLPG3067 in Male Subjects With Cystic Fibrosis. Status COMPLETED Phase PHASE1